Literature DB >> 11257364

Update on hepatitis B vaccination in Italy 10 years after its implementation.

A R Zanetti1.   

Abstract

Since the beginning of the Italian program of immunization against hepatitis B, vaccine has been given to more than 9 million children, with an outstanding record of safety and efficacy. The coverage rate is globally around 94%, with differences between Northern and Southern regions, the latter having the lower acceptance rate. According to the National Surveillance System (SEIEVA), the incidence of acute hepatitis B per10(5) inhabitants declined from 5.4 in 1990 to 2.9 in 1998. The reduction was even greater among 15-24-year-old individuals, where the incidence rate per 10(5) decreased from 17.3 to 4.2 in the same period. In parallel with the decline of hepatitis B, Delta hepatitis has also dropped significantly. We expect that by the year 2003 (12 years after the beginning of the program) this vaccination strategy will have led to the protection of all Italians aged 0-24 years, who are those at the higher risk for acquiring hepatitis B virus (HBV) and for developing the chronic carrier state.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257364     DOI: 10.1016/s0264-410x(00)00458-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Vaccination and rheumatoid arthritis.

Authors:  J Sibilia; J F Maillefert
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

Review 2.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

3.  Long-term persistence of immunity after hepatitis B vaccination: A fact, not a fancy.

Authors:  Andrea Trevisan
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

4.  Rate of acquired immunity in dental students after hepatitis B vaccination.

Authors:  Eshagh Lasemi; Neda Haddadpour; Fina Navi; Aghdas Rakhshan; Vahid Rakhshan
Journal:  Dent Res J (Isfahan)       Date:  2011

5.  Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.

Authors:  Guglielmo Dini; Alessandra Toletone; Ilaria Barberis; Nicoletta Debarbieri; Emanuela Massa; Chiara Paganino; Francesca Bersi; Alfredo Montecucco; Cristiano Alicino; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2017-02       Impact factor: 3.452

6.  Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy.

Authors:  Giuseppe Grosso; Antonio Mistretta; Stefano Marventano; Roberta Ferranti; Luisa Mauro; Rosario Cunsolo; Lidia Proietti; Mariano Malaguarnera
Journal:  Hepat Mon       Date:  2012-09-04       Impact factor: 0.660

7.  Associated factors for recommending HBV vaccination to children among Georgian health care workers.

Authors:  Maia Butsashvili; George Kamkamidze; Marina Topuridze; Dale Morse; Wayne Triner; Jack DeHovitz; Kenrad Nelson; Louise-Anne McNutt
Journal:  BMC Infect Dis       Date:  2012-12-20       Impact factor: 3.090

Review 8.  Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update.

Authors:  Raymond S Koff
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.487

9.  Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors.

Authors:  A Stefanati; N Bolognesi; F Sandri; G Dini; E Massa; A Montecucco; S Lupi; G Gabutti
Journal:  J Prev Med Hyg       Date:  2019-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.